Vigiis 101-LAB (Probiotics,Lactic Acid,Lactobacillus Paracasei,Gut,Immunity,Allergy,NTU101,Gastrointestinal,Microbiota,Clinical)

Key Features(1) Patented strain: Lactobacillus paracasei subsp. paracasei NTU 101(2) Multi-national patents (Taiwan, China, the USA, the EU, Japan)(3) More than 26 research publications(4) More-than-ten-year research by the National Taiwan University research team(5) In vivo and in vitro experiments to prove its benefits(6) Scientifically researched functions focus on prevention of gastricmucosal lesions, immunomodulation, alleviation of allergies, modification of the intestinal microflora(7) Safety assessments include 28-day feeding toxicity study and genotoxicity study(8) HACCP, ISO 22000 certification(9) Specification: powders, ≥ 1011 CFU/g(10) Daily dosage: 50 mg(11) For more information on Lactobacillus paracasei subsp. paracasei NTU 101, you may also visit Dr. Pan and his research team at National Taiwan University at here.